MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha(Austrian Academy of Sciences), Florian Grebien(University of Veterinary Medicine Vienna)
Cited by 57
Related Papers
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
|Nature Chemical Biology|2012|96
Roles of SETD2 in Leukemia—Transcription, DNA-Damage, and Beyond
|International Journal of Molecular Sciences|2019|70
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia
|Nature Communications|2023|40
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
|DSpace@MIT (Massachusetts Institute of Technology)|2012|2